Skip to main navigation Skip to search Skip to main content

Probiotics Prescribed With Helicobacter pylori Eradication Therapy in Europe: Usage Pattern, Effectiveness, and Safety. Results From the European Registry on Helicobacter pylori Management (Hp-EuReg)

  • Diego Casas Deza
  • , Javier Alcedo
  • , Miguel Lafuente
  • , F. Javier López
  • , Ángeles Perez-Aisa
  • , Matteo Pavoni
  • , Bojan Tepes
  • , Laimas Jonaitis
  • , Manuel Castro-Fernandez
  • , Manuel Pabón-Carrasco
  • , Alma Keco-Huerga
  • , Irina Voynovan
  • , Luis Bujanda
  • , Alfredo J. Lucendo
  • , Natasa Brglez Jurecic
  • , Maja Denkovski
  • , Ludmila Vologzanina
  • , Luis Rodrigo
  • , Samuel J. Martínez-Domínguez
  • , Galyna Fadieienko
  • Jose M. Huguet, Rustam Abdulkhakov, Sayar R. Abdulkhakov, Noelia Alcaide, Benito Velayos, Luis Hernández, Dmitry S. Bordin, Antonio Gasbarrini, Juozas Kupcinskas, Gülüstan Babayeva, Oleksiy Gridnyev, Mārcis Leja, Theodore Rokkas, Ricardo Marcos-Pinto, Frode Lerang, Doron Boltin, Antonio Mestrovic, Sinead M. Smith, Marino Venerito, Lyudmila Boyanova, Vladimir Milivojevic, Michael Doulberis, Lumir Kunovsky, Pablo Parra, Anna Cano-Català, Leticia Moreira, Olga P. Nyssen, Francis Megraud, Colm O. Morain, Javier P. Gisbert
  • University of Zaragoza
  • University of the Basque Country
  • University of Oviedo
  • Hospital Clinico Universitario Lozano Blesa
  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS
  • University of Porto
  • Tel Aviv University
  • Clinical Center of Serbia
  • University of Barcelona

Research output: Contribution to journal › Article › peer-review

16 Citations (Scopus)

Abstract

INTRODUCTION: – To evaluate the prescription patterns, effectiveness, and safety of adding probiotics to Helicobacter pylori eradication therapy, in Europe. METHODS: – International, prospective, noninterventional registry of the clinical practice of the European gastroenterologists. Data were collected and quality reviewed until March 2021 at AEG-REDCap. The effectiveness was evaluated by modified intention-to-treat analysis, differentiating by geographic areas. Adverse events (AEs) were categorized as mild, moderate, and severe. RESULTS: – Overall, 36, 699 treatments were recorded, where 8, 233 (22%) were prescribed with probiotics. Probiotics use was associated with higher effectiveness in the overall analysis (odds ratio [OR] 1.631, 95% confidence interval [CI] 1.456–1.828), as well as in triple (OR 1.702, 95% CI 1.403–2.065), quadruple (OR 1.383, 95% CI 0.996–1.920), bismuth quadruple (OR 1.248, 95% CI 1.003–1.554), and sequential therapies (OR 3.690, 95% CI 2.686–5.069). Lactobacillus genus was associated with a higher therapy effectiveness in Eastern Europe when triple (OR 2.625, 95% CI 1.911–3.606) and bismuth quadruple (OR 1.587, 95% CI 1.117–2.254) first-line therapies were prescribed. In Central Europe, the use of probiotics was associated with a decrease in both the overall incidence of AEs (OR 0.656, 95% CI 0.516–0.888) and severe AEs (OR 0.312, 95% CI 0.217–0.449). Bifidobacterium genus was associated with lower overall (OR 0.725, 95% CI 0.592–0.888) and severe (OR 0.254, 95% CI 0.185–0.347) AEs, and Saccharomyces was associated with reduced overall (OR 0.54, 95% CI 0.32–0.91) and severe (OR 0.257, 95% CI 0.123–0.536) AEs under quadruple-bismuth regimen. DISCUSSION: – In Europe, the use of probiotics was associated with higher effectiveness and safety of H. pylori eradication therapy. Lactobacillus improved treatment effectiveness, whereas Bifidobacterium and Saccharomyces were associated with a better safety profile.

Original languageEnglish
Pages (from-to)2644-2659
JournalAmerican Journal of Gastroenterology
Volume120
Issue number11
DOIs
Publication statusPublished - Nov 2025

OECD Field of Science

  • 3. Medical and Health Sciences

Keywords

  • effectiveness
  • eradication therapy
  • probiotics
  • safety

Fingerprint

Dive into the research topics of 'Probiotics Prescribed With Helicobacter pylori Eradication Therapy in Europe: Usage Pattern, Effectiveness, and Safety. Results From the European Registry on Helicobacter pylori Management (Hp-EuReg)'. Together they form a unique fingerprint.

Cite this